Published in Women's Health Weekly, October 6th, 2005
"The standard of care for ST-segment elevation myocardial infarction (STEMI) is prompt coronary reperfusion with thrombolysis or percutaneous coronary intervention." According to researchers at Newark Beth Israel Medical Center, "Women have higher mortality rates than men following STEMI and fewer women are considered eligible for reperfusion therapy."
M. Cohen and colleagues "analyzed the impact of gender, and other factors, on the outcome and treatment of STEMI in the TETAMI trial and registry. This exploratory analysis included 2741...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly